Safety Profile of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Integrated Data used in the US Prescribing Information. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s572. https://doi.org/10.25251/skin.10.supp.572